5D Patient Journey
New Rochelle, US · Founded 2026 · Delaware corporation
Founders & leadership
ES
Eric SchadtNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 2 rounds · 2026
▶$5.5MraisedJun 2026 · 5 investors · BiotechnologyRule 506(b)
▶$5.5MraisedJun 2026 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel ClarkExecutive Officer
- Erick DaiExecutive Officer
- Eric SchadtExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $5.5M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
▶$80raisedMar 2026 · 4 investors · BiotechnologyRule 506(b)
▶$80raisedMar 2026 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric SchadtExecutive Officer, Director
- Offering amount
- $80
- Amount sold
- $80
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has 5D Patient Journey raised?
- 5D Patient Journey has disclosed $5.5M raised across 2 rounds.
- Where is 5D Patient Journey headquartered?
- 5D Patient Journey is headquartered in New Rochelle, US.